Hooper, J W <br/><br/>
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.  [electronic resource] 

 -  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  May 2014 
 - 110-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1469-0691 
<br/><br/><label>Standard No.: </label>10.1111/1469-0691.12553  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Electroporation<br/>Female<br/>Hantaan virus--genetics<br/>Hemorrhagic Fever with Renal Syndrome--prevention & control<br/>Humans<br/>Injections, Intramuscular<br/>Male<br/>Middle Aged<br/>Neutralization Tests<br/>Puumala virus--genetics<br/>Vaccination<br/>Vaccines, DNA--administration & dosage<br/>Viral Vaccines--administration & dosage<br/>Young Adult